Hubei Goto Biopharm News

Kyodo Pharmaceutical: Announcement on the 2024 Interest Payment of Mutual Convertible Bonds

Nov 21 17:22

Kyodo Pharmaceutical: Announcement on the Election of Staff Representative Supervisors for the 3rd Board of Supervisors

Oct 16 20:32

Kyodo Pharmaceutical: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior management

Oct 16 20:32

Kyodo Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Oct 16 20:02

Kyodo Pharmaceutical: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hubei Kyodo Pharmaceutical Co., Ltd.

Oct 16 20:02

Kyodo Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024

Oct 8 16:16

Kyodo Pharmaceutical: Announcement on the election of the board of directors for a new term

Oct 1 00:00

Kyodo Pharmaceutical: Announcement on the election of the Supervisory Board for a new term

Oct 1 00:00

Kyodo Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024

Oct 1 00:00

Kyodo Pharmaceutical: Dongfang Jincheng International Credit Evaluation Co., Ltd.\'s notice on Hubei Kyodo Pharmaceutical Co., Ltd.\'s 2024 semi-annual performance loss

Sep 18 16:36

Kyodo Pharmaceutical: Announcement on changing the sponsor representative for continuous supervision

Sep 13 17:02

Kyodo Pharmaceutical: 2024 Semi-Annual Financial Report

Aug 28 00:00

Kyodo Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024

Aug 28 00:00

Hubei Goto Biopharm: Legal opinion from Beijing Zhonglun (Wuhan) Law Firm regarding the 2024 second extraordinary general meeting of shareholders of Hubei Jointown Pharmaceutical Co., Ltd.

Aug 9 18:24

Hubei Goto Biopharm: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.

Aug 9 18:24

Hubei Goto Biopharm: Announcement regarding not downwardly revising the price of debt-for-equity swaps.

Aug 7 17:52

Hubei Goto Biopharm: Announcement on the conditions for downward revision of the expected conversion price of convertible bonds.

Jul 31 17:46

Hubei Goto Biopharm: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.

Jul 25 00:00

Hubei Goto Biopharm: Announcement regarding the wholly-owned subsidiary's plan to apply for a comprehensive credit limit from banks and the company providing guarantee for it.

Jul 25 00:00

Hubei Goto Biopharm: Announcement on the conversion of convertible corporate bonds to stocks in Q2 2024.

Jul 1 17:12